Evidence map›Paper›PMID 40491661›Full record

ArticleContemporary clinical trials communications2025

Links between self-monitoring data collected through smartphones and smartwatches and the individual disease trajectories of adult patients with depressive disorders: Study protocol of a one-year observational trial.

Hanna Reich, Simon Schreynemackers, Rebeka Amin, Sascha Ludwig, Jil Zippelius, Johannes Leimhofer, Tobias Dunker, Elisabeth Schriewer, Angela Carell, Yvonne Weber and 2 more

Abstract read
In one paragraph

Article in Contemporary clinical trials communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hanna ReichResearch Centre of the German Foundation for Depression and Suicide Prevention, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital, Goethe University, Heinrich-Hoffmann-Straße 10, 60528, Frankfurt am Main, Germany.
Simon SchreynemackersResearch Centre of the German Foundation for Depression and Suicide Prevention, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital, Goethe University, Heinrich-Hoffmann-Straße 10, 60528, Frankfurt am Main, Germany.
Rebeka AminResearch Centre of the German Foundation for Depression and Suicide Prevention, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital, Goethe University, Heinrich-Hoffmann-Straße 10, 60528, Frankfurt am Main, Germany.
Sascha LudwigInstitute for Applied Informatics, University Leipzig, Goerdelerring 9, 04109, Leipzig, Germany.
Jil ZippeliusResearch Centre of the German Foundation for Depression and Suicide Prevention, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital, Goethe University, Heinrich-Hoffmann-Straße 10, 60528, Frankfurt am Main, Germany.
Johannes LeimhoferResearch Centre of the German Foundation for Depression and Suicide Prevention, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital, Goethe University, Heinrich-Hoffmann-Straße 10, 60528, Frankfurt am Main, Germany.
Tobias Dunkeradesso SE, Business Line Health, Adessoplatz 1, 44269, Dortmund, Germany.
Elisabeth SchriewerDepartment of Epileptology and Neurology, University RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.
Angela Carelladesso SE, Business Line Health, Adessoplatz 1, 44269, Dortmund, Germany.
Yvonne WeberDepartment of Epileptology and Neurology, University RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.
Ulrich HegerlGerman Foundation for Depression and Suicide Prevention, Goerdelerring 9, 04109, Leipzig, Germany.
MONDY consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depression is highly recurrent and heterogenous in its individual course, requiring a personalized treatment approach. Patients today can collect large volumes of personal data via smartphones and smartwatches and may utilize them for their treatment and self-management. We aim to provide proof-of-concept that these data can (i) serve as an objective marker of and (ii) predict the daily and weekly self-reported depression severity within individuals with depressive disorders. In this exploratory study, 15 adult patients with depressive disorders will collect self-report and biosensor data over the course of one year. Participants will (a) attend three in-person appointments (at baseline, 6 months, and 12 months), (b) self-report daily and weekly depressive symptoms, (c) continuously collect sensor data via the "iTrackDepression" app on their Android smartphone (app usage, phone calls, phonetic parameters from voice recordings), and (d) wear a Samsung Galaxy Watch 5® to record data from the accelerometer, step sensor, light sensor, and heart rate sensor. We will apply multilevel correlations, vector-autoregressive models, and Machine Learning approaches to identify individual patterns in the data, particularly in the relationships between biosensor data and self-reported depressive symptoms. Enhancing the understanding of individual disease trajectories through data from smartphones and smartwatches could allow for classical, digital, and self-management interventions for depression to be delivered in a manner and at a time specifically tailored to the individual's needs. Clinical trial registration number: DRKS00032618 (https://drks.de/search/en/trial/DRKS00032618).

Indexed as

Ambulatory assessmentDepressionDigital phenotypingForecastingMachine learningn-of-1 designPassive sensingProof-of-conceptSmartphoneSmartwatchVAR-models

Identifiers

PMID40491661
PMCPMC12148402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.